TRX818

CAS No. 1256037-58-7

TRX818( —— )

Catalog No. M17224 CAS No. 1256037-58-7

TRX-818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 50 In Stock
5MG 88 In Stock
10MG 143 In Stock
25MG 216 In Stock
50MG 333 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TRX818
  • Note
    Research use only, not for human use.
  • Brief Description
    TRX-818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
  • Description
    TRX-818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    c-Met/HGFR
  • Recptor
    Others
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1256037-58-7
  • Formula Weight
    393.21
  • Molecular Formula
    C16H11FNNa2O5P
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    c12c(c(c(cc1)OC)P(=O)([O-])[O-])c(=O)cc([nH]2)c1cc(ccc1)F.[Na+].[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Salidroside

    Salidroside is a bioactive phenolic glycoside compound isolated from Rhodiola crenulata. It is a prolyl endopeptidase Inhibitor.

  • Cabozantinib hydroch...

    Cabozantinib (XL184) is a potent pan-tyrosine kinases inhibitor that inhibits VEGFR2 c-Met Kit Axl and Flt4 (IC50s: 0.035 1.3 4.6 7 and 6 nM).

  • SOMG-833

    A potent, selective, ATP-competitive c-MET inhibitor with IC50 of 0.93 nM.